PCI Biotech Holding ASA will be transferred to Oslo Børs from 27.04.2018 NewsRonny SkuggedalApril 27, 2018
Publication of prospectus summary for transfer of listing to Oslo Børs NewsRonny SkuggedalApril 25, 2018
Exercise of employee share options and resolution to increase the share capital NewsRonny SkuggedalApril 12, 2018
Extension of preclinical research collaboration agreement with a top-10 large pharma company NewsRonny SkuggedalJanuary 18, 2018
PCI Biotech announces preliminary outcome of meetings with EMA and FDA for development of fimaporfin in inoperable cholangiocarcinoma NewsRonny SkuggedalDecember 20, 2017
